ArticleDiscover oncology2024

Development of a novel centrosome-related risk signature to predict prognosis and treatment response in lung adenocarcinoma.

Ziqiang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.